Epidemiology and treatment of epilepsy in patients who are mentally retarded

CNS Drugs

Volumn 13, Issue 2, 2000, Pages 117-128

  Deb, Shoumitro ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; DIAZEPAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; LORAZEPAM; MIDAZOLAM; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

AGRANULOCYTOSIS; ANTICONVULSANT THERAPY; APLASTIC ANEMIA; ARTICLE; ATAXIA; COMORBIDITY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; EPILEPSY; HAIR LOSS; HIRSUTISM; HUMAN; INCIDENCE; MEGALOBLASTIC ANEMIA; MENTAL DEFICIENCY; NEUROSURGERY; PREVALENCE; PRIORITY JOURNAL; RASH; SLEEP DISORDER; SOMNOLENCE; TREMOR; VERTIGO;

EID: 0034007878     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200013020-00005     Document Type: Article

References (67)

1. Sillanpää M, Gram L, Johannessen SI, et al. Epilepsy and mental retardation. Philadelphia (PA): Wrightson Biomedical Publishing Limited, 1999
2. Kotagal P, Lüders HO. The epilepsies: etiology and prevention. San Diego (CA): Academic Press, 1999
3. Forsgren I, Edvinsson SO, Blomquist HK, et al. Epilepsy in a population of mentally retarded children and adults. Epilepsy Res 1990; 6 (3): 234-48
4. Goulden KJ, Shinnar S, Koller H, et al. Epilepsy in children with mental retardation; a cohort study. Epilepsia 1991; 32 (5): 690-7
5. McGrother CW, Hauck A, Bhaumik S, et al. Community care for adults with learning disability and their carers: needs and outcome from the Leicestershire register. J Intellect Disabil Res 1996; 40 (2): 183-90
6. Deb S. Epilepsy and mental retardation. Epilepsie Bull 1997; 25: 91-4
7. Rutter M, Tizard J, Yule W, et al. Research report: Isle of Wight Studies, 1964-1974. Psychol Med 1976; 6 (3): 313-32
8. Shepherd C, Hosking G. Epilepsy in school children with intellectual impairment in Sheffield: the size and nature of the problem and its implications in service provision. J Ment Defic Res 1989; 33 (Pt 6): 511-4
9. Steffenburg U, Hagberg G, Kyllerman M. Characteristics of seizures in a population-based series of mentally retarded children with active epilepsy. Epilepsia 1996; 37: 850-6
10. Michelucci R, Forti A, Rubboli G, et al. Mental retardation and behavioural disturbances related to epilepsy: a review. Brain Dysfunction 1989; 2 (1): 3-9
11. Suzuki H, Aihara M, Sugai K. Severely retarded children in a defined area of Japan: prevalence rate, associated disabilities and causes. Brain Dev 1991; 23 (1): 4-8
12. Benedetti BD, Dov I, Hauser WA, et al. Frequency of seizures among children with cerebral palsy and mental retardation [abstract]. Dev Med Child Neurol 1986: 28 Suppl. 53: 36
13. Hauser WA. Risk factors for epilepsy. In: Kotagal P, Lüders HO, editors. The epilepsies: etiology and prevention. San Diego (CA): Academic Press, 1999: 1-11
14. Stafstorm CE. Mechanisms of epilepsy in mental retardation: insight from Angelman syndrome, Down syndrome and Fragile X syndrome. In: Sillanpää M, Gram L, Johannessen SI, et al., editors. Epilepsy and mental retardation. Philadelphia (PA): Wrightson Biomedical Publishing Limited, 1999: 7-40
15. Deb S, Ahmed Z. Special conditions leading to mental retardation. In: Gelder MG, Andreasen N, Lopez-Ibor JJ, editors. New Oxford Textbook of Psychiatry. Oxford University Press. In press
16. Lund J. Epilepsy and psychiatric disorder in the mentally retarded adults. Acta Psychiatr Scand 1985; 72: 557-62
17. Deb S, Joyce J. Characteristics of epilepsy in a population bases cohort of adults with learning disability. Ir J Psychol Med 1999; 16 (1): 5-9
18. Murphy CC, Trevathan E, Yeargin-Allsopp M. Prevalence of epilepsy and epileptic seizures in 10-year old children: results from the Metropolitan Atlanta Developmental Disability Study. Epilepsia 1995; 36 (9): 866-72
19. Sillanpää M. Medico-social prognosis or children with epilepsy. Epidemiological study and analysis of 245 cases. Acta Paediatr Scand 1973: Suppl. 237: 1-104
20. Trevathan E, Murphy CC, Yeargin-Allsopp M. Prevalence and descriptive epidemiology of Lennox-Gastaut syndrome among Atlanta children. Epilepsia 1997; 38: 1283-8
21. Sillanpää M. Definitions and epidemiology. In: Sillanpää M, Gram L, Johannessen SI, et al., editors. Epilepsy and mental retardation. Philadelphia (PA): Wrightson Biomedical Publishing Limited, 1999: 1-6
22. Dobyns WB, Truwit CL. Lissencephaly and other malformations of cortical development: 1995 update. Neuropediatric 1995; 26: 132-47
23. Li LM, Fish DR, Sisodiya SM, et al. High resolution magnetic resonance imaging in adults with partial or secondary generalised epilepsy attending a tertiary referral unit. J Neurol Neurosurg Psychiatry 1995; 59: 384-7
24. Deb S. Strutural neuroimaging in mental retardation. Br J Psychiatry 1997; 171: 417-9
25. Cataltepe O, Comair YG. Focal resection in the treatment of neuronal migrational disorders. In: Kotagal P, Lüders HO, editors. The epilepsies: etiology and prevention. San Diego (CA): Academic Press, 1999: 87-92
26. Holthausen H, Tuxhorn I, Pieper T, et al. Hemispherectomy in the treatment of neuronal migrational disorders. In: Kotagal P, Lüders HO, editors. The epilepsies: etiology and prevention. San Diego (CA): Academic Press, 1999: 93-102
27. Roberts DW. Corpus callosotomy in the treatment of neuronal migrational disorders. In: Kotagal P, Lüders HO, editors. The epilepsies: etiology and prevention. San Diego (CA): Academic Press, 1999: 103-12
28. Lehesjoki A-E, Koskiniemi M, Sistonen P, et al. Localisation of a gene for progressive myoclonus epilepsy to chromosome 21q22. Proc Natl Acad Sci U S A 1991; 88: 3696-9
29. Eubanks JH, Puranam RS, Kleckner N, et al. The gene encoding the glutamate receptor subunit GluR5 is located on human chromosome 21q21.1-22.1 in the vicinity of the gene for familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 1993; 90 (1): 178-82
30. Wisniewski KE, French JH, Fernando S et al. Fragile x syndrome: associated neurological abnormalities. Ann Neurol 1985; 18: 665-9
31. Betts T. Pseudoseizures: seizures that are not epilepsy. Lancet 1990; 336: 163-4
32. Coulter DL. Epilepsy and mental retardation: an overview. Am J Ment Retard 1993; 98 (5): 1-11
33. Deb S. Electrophysiological correlates of psychopathology in individuals with mental retardation and epilepsy. J Intellect Disabil Res 1995; 39: 129-35
34. Alvarez N, Besag F, Iivanianen M. Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability. J Intellect Disabil Res 1998; 42 Suppl. 1: 1-15
35. Deb S, Hunter D. The effect of anticonvulsant medication on the psychopathology of adults with a mental handicap and epilepsy. Hum Psychopharmacol 1992; 7: 129-34
36. Deb S, Joyce J. The use of antiepileptic medication in a population based cohort of adults with learning disability and epilepsy. Int J Psychiatry Clin Pract 1999; 3: 129-33
37. Collacott RA, Dignon A, Hauck A, et al. Clinical and therapeutic monitoring of epilepsy in a mental handicap unit. Br J Psychiatry 1989; 155: 522-5
38. Pellock JM, Hunt PA. A decade of modern epilepsy therapy in institutionalised mentally retarded patients. Epilepsy Res 1996; 25: 263-8
39. British National Formulary. No. 38. London: British Medical Association and the Royal Pharmaceutical Society of Great Britain, 1999
40. Alvarez N. Barbiturates in the treatment of epilepsy in people with intellectual disability. J Intellect Disabil Res 1998; 42 Suppl. 1: 16-23
41. Iivanianen M. Phenytoin: effective but insidious therapy for epilepsy in people with intellectual disability. J Intellect Disabil Res 1998; 42 Suppl. 1: 24-31
42. Aldenkamp AP, van Bronswijk K. Cognitive side-effects as an outcome measure in antiepileptic drug treatment: the current debate. In: Sillanpää M, Gram L, Johannessen SI, et al., editors. Epilepsy and mental retardation. Philadelphia (PA): Wrightson Biomedical Publishing Limited, 1999: 135-46
43. Friis ML. Valproale in the treatment of epilepsy in people with intellectual disability. J Intellect Disabil Res 1998; 42 Suppl. 1: 32-5
44. Deb S. Mental disorder in adults with mental retardation and epilepsy. Compr Psychiatry 1997; 38 (3): 179-84
45. Weisburg H, Alvarez N. Carbamazepine in the treatment of epilepsy in people with intellectual disability. J Intellect Disabil Res 1998; 42 Suppl. 1: 36-40
46. Friedman DL, Kastner T, Plummer AT, et al. Adverse behavioral effects in individuals with mental retardation and mood disorders treated with carbamazepine. Am J Mental Retard 1992; 96 (5): 541-6
47. Gaily E, Granstrom M-L, Lliukkonen E. Oxcarbazepine in the treatment of epilepsy in children and adolescents with intellectual disability. J Intellect Disabil Res 1998; 42 Suppl. 1: 41-5
48. Besag FMC. Lamotrigine in the treatment of epilepsy in people with intellectual disability. J Intellect Disabil Res 1998; 42 Suppl. 1: 50-6
49. Dulac O, Kaminska A. Use of lamotrigine in Lennox-Gestaut and related epilepsy syndromes. J Child Neurol 1997; 12 Suppl. 1: S23-8
50. Genton P, Dravet C, Bureau N, et al. Aggravation of severe myoclonic epilepsy of infancy by lamotrigine [abstract]. Epilepsia 1997: 38 Suppl. 3: 32
51. Beran RG, Gibson RJ. Aggressive behaviour in intellectually challenged patients with epilepsy treated with lamotrigine. Epilepsia 1998; 39: 280-2
52. Ylinen A. Antiepileptic efficacy of vigabatrin in people with severe epilepsy and intellectual disability. J Intellect Disabil Res 1998; 42 Suppl. 1: 46-9
53. Ramsay RE, Slater JD. Antiepileptic drugs in clinical development. In: French JA, Dichter MA, Leppik IE, editors. New antiepileptic drug development, preclinical and clinical aspects (Epilepsy Research: Supplement No. 10). Oxford: Elsevier Science Ltd, 1993: 45-67
54. Bhaumik S, Branford D, Duggirala C, et al. A naturalistic study of the use of vigabatrin, lamotrigine and gabapentin in adults with learning disabilities. Seizure 1997; 6: 127-33
55. Eke T, Talbot JE, Lawden MC. Severe persistent visual field constriction association with vigabatrin. BMJ 1997; 314: 180-1
56. Mikati MA, Chouerir, Khurana DS, et al. Gabapentin in the treatment of refractory partial epilepsy in children with intellectual disability. J Intellect Disabil Res 1998; 42 Suppl. 1: 57-62
57. Kerr MP. Topiramate; uses in people with an intellectual disability who have epilepsy. J Intellect Disabil Res 1998; 42 Suppl. 1: 74-9
58. Iinuma K, Minami T, Cho K, et al. Long term effects of Zonisamide in the treatment of epilepsy in children with intellectual disability. J Intellect Disabil Res 1998; 42 Suppl. 1: 68-73
59. Kälväiinen R. Tiagabine: a new therapeutic option for people with intellectual disability and partial epilepsy. J Intellect Disabil Res 1998; 42 Suppl. 1: 63-7
60. Leppik JE, Wolff DL. The place of felbamate in the treatment of epilepsy. CNS Drugs 1995; 4 (4): 294-301
61. Ben-Menachem E, Henriksen O, Johannessen SI. Diagnosis and treatment of partial seizures. CNS Drugs 1999; 11 (1): 23-39
62. Isojärvi JIT, Tokola RA. Benzodiazepine in the treatment of epilepsy in people with intellectual disability. J Intellect Disabil Res 1998; 42 Suppl. 1; 80-92
63. Scheepers M, Scheepers B, Clough P. Midazolam via the intranasal route: an effective treatment rescue medication for severe epilepsy in adults with a learning disability. Seizure 1998; 7: 509-12
64. Henriksen O, Bjørnaes H, Røste GK. Epilepsy surgery in mental retardation: the role of surgery. In: Sillanpää M, Gram L, Johannessen SI, et al., editors. Epilepsy and mental retardation. Philadelphia (PA): Wrightson Biomedical Publishing Limited, 1999: 105-13
65. Brodie MJ, Yuen AWC, and the 105 Study Group. Lamotrigine substitution study: evidence for synergism with sodium valproate? Epilepsy Res 1997; 26: 423-32
66. Stephen LJ, Sills GJ, Brodie MJ. Lamotrigine and topiramate may be a useful combination. Lancet 1998; 351: 958-9
67. Deb S, Fraser WI. The use of psychotropic medication in people in people with learning disability: towards rational prescribing. Hum Psychopharmacol 1994; 9: 259-72